(IPX) IperionX American - Ratings and Ratios
Titanium, Rare Earth Elements, Zircon, Mineral Sands
IPX EPS (Earnings per Share)
IPX Revenue
Description: IPX IperionX American
IperionX Limited is a mining company focused on developing its mineral properties in the United States, with a primary focus on the Titan project in Tennessee, which is rich in titanium, rare earth, and zircon minerals. The companys operations support various industries, including consumer electronics, aerospace, and automotive, by producing titanium products from scrap titanium at its industrial pilot facility in Utah.
The companys business model is centered around the production of critical minerals and titanium products, which are essential for various high-tech and industrial applications. With its Titan project covering approximately 11,054 acres, IperionX Limited is well-positioned to capitalize on the growing demand for these minerals. The companys titanium products are used in a range of applications, from aerospace and defense to medical and consumer electronics.
From a market perspective, IperionX Limiteds American Depositary Share (NASDAQ:IPX) has shown significant price movement, with a current price of $27.56 and a 52-week high of $38.02. The companys market capitalization stands at $906.69M USD, with a forward P/E ratio of 1250.00, indicating high growth expectations. The lack of a traditional P/E ratio is likely due to the companys current loss-making status, as indicated by the negative RoE of -0.04.
Using the available technical and fundamental data, a forecast for IPX can be made. The stocks SMA20, SMA50, and SMA200 indicators suggest a bullish trend, with the short-term SMA20 at $26.11 and the long-term SMA200 at $23.80. The ATR of 1.65 (5.99%) indicates moderate volatility. Given the companys strong growth prospects and the increasing demand for critical minerals, it is likely that the stock price will continue to rise. A potential target price could be $35.00, representing a 27% increase from the current price. However, this forecast is subject to various risks, including market volatility and changes in commodity prices.
Additional Sources for IPX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IPX Stock Overview
Market Cap in USD | 880m |
Sector | Basic Materials |
Industry | Other Industrial Metals & Mining |
GiC Sub-Industry | Diversified Metals & Mining |
IPO / Inception | 2022-06-21 |
IPX Stock Ratings
Growth Rating | 64.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 102 |
Analysts | 5 of 5 |
Fair Price Momentum | 33.10 USD |
Fair Price DCF | - |
IPX Dividends
Currently no dividends paidIPX Growth Ratios
Growth Correlation 3m | 92.7% |
Growth Correlation 12m | 43% |
Growth Correlation 5y | 94.1% |
CAGR 5y | 65.63% |
CAGR/Max DD 5y | 1.00 |
Sharpe Ratio 12m | 0.18 |
Alpha | 102.95 |
Beta | 1.474 |
Volatility | 71.56% |
Current Volume | 196.6k |
Average Volume 20d | 50.8k |
Stop Loss | 31.2 (-5.2%) |
As of July 14, 2025, the stock is trading at USD 32.90 with a total of 196,560 shares traded.
Over the past week, the price has changed by +18.09%, over one month by +26.73%, over three months by +119.19% and over the past year by +109.15%.
Yes. Based on ValueRay's Analyses, IperionX American (NASDAQ:IPX) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 64.85 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IPX is around 33.10 USD . This means that IPX is currently overvalued and has a potential downside of 0.61%.
IperionX American has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy IPX.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, IPX IperionX American will be worth about 39.7 in July 2026. The stock is currently trading at 32.90. This means that the stock has a potential upside of +20.7%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 35 | 6.4% |
Analysts Target Price | 35 | 6.4% |
ValueRay Target Price | 39.7 | 20.7% |